Using human serum and plasma to determine novel biomarkers for neurodegenerative diseases

Taking results from animal models, this project will screen blood lipids found to be markers of disease progression. Serum and plasma samples accessed from SALSA-SGC will be used for targeted screening of blood lipids knowing that lipid metabolism plays a crucial role in MND. This research will be conducted at the Florey Institute in Melbourne, Victoria, and results are expected late 2022. Interested in finding out more about this study? Please contact Sophia Luikinga: